Uridine Triacetate Patent Expiration
Uridine Triacetate was first introduced by Btg International Inc
Uridine Triacetate Patents
Given below is the list of patents protecting Uridine Triacetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vistogard | US7776838 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | Aug 17, 2027 | Btg Intl |
| Vistogard | US6258795 | Acylated uridine and cytidine and uses thereof |
Jul 10, 2023
(Expired) | Btg Intl |
| Xuriden | US6258795 | Acylated uridine and cytidine and uses thereof |
Jul 10, 2023
(Expired) | Btg Intl |
| Vistogard | US5968914 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
Oct 19, 2016
(Expired) | Btg Intl |
Uridine Triacetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List